Metabolic-associated steatotic liver disease (MASLD) is a clinically heterogeneous condition with highly variable outcomes affecting more than 30%...
Vous n'êtes pas connecté
Maroc - NEWS.MEDICAL.NET - A la Une - 11/09/2024 06:08
Using a novel stem cell platform, a team of the Medical University of South Carolina researchers has identified a pathway that could be targeted by drugs to reduce fat accumulation in patients with a common form of fatty liver disease known as metabolic dysfunction-associated steatotic liver disease, or MASLD.
Metabolic-associated steatotic liver disease (MASLD) is a clinically heterogeneous condition with highly variable outcomes affecting more than 30%...
Fatty liver disease, also known as metabolic-associated fatty liver disease (MASLD), has become very common in recent years. Around one in three...
As the global burden of obesity, type 2 diabetes, and metabolic syndrome continues to rise, fatty liver disease has become one of the most prevalent...
As the global burden of obesity, type 2 diabetes, and metabolic syndrome continues to rise, fatty liver disease has become one of the most prevalent...
Researchers have identified microRNA-93 as a key genetic driver of fatty liver disease and discovered that vitamin B3 can effectively shut it down....
Fatty liver disease is becoming increasingly common around the world, especially as more people develop conditions such as obesity, diabetes, and...
Doctors warn that even people with normal BMI may carry dangerous visceral fat, increasing the risk of diabetes, heart disease and fatty liver—often...
Steatotic liver disease (SLD) significantly increases heart failure (HF) risk in older adults with atrial fibrillation (AFib).
Fatty liver disease is a condition that happens when too much fat builds up inside the liver. The liver is one of the most important organs in the...
WEDNESDAY, March 19, 2026 — Fatty liver disease is when too much fat builds up in the liver. The liver is the body’s filter. It helps clean your...